ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Astellas Pharma, Inc. ?
1
With a growth in Net Profit of 107.06%, the company declared Outstanding results in Jun 26
- The company has declared positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at JPY 598,027 MM
- ROCE(HY) Highest at 21.31%
- INTEREST COVERAGE RATIO(Q) Highest at 7,549.82
2
With ROE of 15.94%, it has a fair valuation with a 2.12 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 45.03%, its profits have risen by 474.6% ; the PEG ratio of the company is 0
- At the current price, the company has a high dividend yield of 0
3
Majority shareholders : FIIs
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Astellas Pharma, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Astellas Pharma, Inc. for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
Astellas Pharma, Inc.
46.27%
469.09
29.14%
Japan Nikkei 225
60.14%
2.04
29.37%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.35%
EBIT Growth (5y)
10.84%
EBIT to Interest (avg)
27.22
Debt to EBITDA (avg)
0.75
Net Debt to Equity (avg)
0.44
Sales to Capital Employed (avg)
0.76
Tax Ratio
22.47%
Dividend Payout Ratio
47.92%
Pledged Shares
0
Institutional Holding
0.11%
ROCE (avg)
15.79%
ROE (avg)
6.28%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
2.12
EV to EBIT
9.96
EV to EBITDA
6.81
EV to Capital Employed
1.96
EV to Sales
1.95
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
19.69%
ROE (Latest)
15.94%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
OPERATING CASH FLOW(Y)
Highest at JPY 598,027 MM
ROCE(HY)
Highest at 21.31%
INTEREST COVERAGE RATIO(Q)
Highest at 7,549.82
RAW MATERIAL COST(Y)
Fallen by -0.7% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 17.77 %
NET SALES(Q)
Highest at JPY 640,914 MM
OPERATING PROFIT(Q)
Highest at JPY 235,630 MM
OPERATING PROFIT MARGIN(Q)
Highest at 36.76 %
PRE-TAX PROFIT(Q)
Highest at JPY 187,364 MM
NET PROFIT(Q)
Highest at JPY 141,676 MM
EPS(Q)
Highest at JPY 78.96
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Astellas Pharma, Inc.
Operating Cash Flow
Highest at JPY 598,027 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (JPY MM)
Interest Coverage Ratio
Highest at 7,549.82
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales
Highest at JPY 640,914 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Net Sales
At JPY 640,914 MM has Grown at 26.71%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Operating Profit
Highest at JPY 235,630 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JPY MM)
Operating Profit Margin
Highest at 36.76 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at JPY 187,364 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Pre-Tax Profit
At JPY 187,364 MM has Grown at 103.64%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Net Profit
Highest at JPY 141,676 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
Net Profit
At JPY 141,676 MM has Grown at 107.06%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
EPS
Highest at JPY 78.96
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (JPY)
Debt-Equity Ratio
Lowest at 17.77 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -0.7% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
